Cargando…
Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B
Regular prophylactic treatment in severe hemophilia should be considered an optimal treatment. There is no general agreement on the optimal prophylaxis regimen, and adherence to prophylaxis is a main challenge due to medical, psychosocial, and cost controversies. Improved approaches in prophylaxis r...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138045/ https://www.ncbi.nlm.nih.gov/pubmed/27942241 http://dx.doi.org/10.2147/JBM.S84597 |